What evaluation should be performed for a patient who had a serum protein electrophoresis (SPEP) one week ago and now shows worsening leukocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Evaluation for Worsening Leukocytosis After Recent SPEP

Repeat the SPEP with immunofixation and add serum free light chain (sFLC) assay immediately, along with a complete blood count with manual differential to assess for progression of a plasma cell dyscrasia or development of a hematologic malignancy.

Immediate Laboratory Workup

The combination of a recent SPEP and now worsening WBC elevation requires urgent clarification of whether this represents:

  • Progression of a monoclonal gammopathy (AL amyloidosis, multiple myeloma, CLL)
  • A new hematologic malignancy
  • A reactive leukocytosis

Essential Tests to Order Now:

Complete the monoclonal protein workup 1:

  • Repeat SPEP with immunofixation - SPEP alone can miss small monoclonal proteins; immunofixation is mandatory
  • Serum free light chain assay with kappa/lambda ratio - An abnormal sFLC ratio raises suspicion for AL amyloidosis or plasma cell dyscrasia even when SPEP appears normal
  • 24-hour urine protein electrophoresis with immunofixation - Essential if serum M-protein >1.5 g/dL or if multiple myeloma/AL amyloidosis suspected 2

Assess the leukocytosis 3:

  • CBC with manual differential (not automated) - Look specifically for:
    • Absolute lymphocyte count and morphology (small mature lymphocytes suggest CLL)
    • Presence of blasts or dysplastic changes
    • Left shift or elevated band count
    • Platelet count and mean corpuscular volume (MCV)
  • Peripheral blood smear review - Critical for identifying abnormal cells

Additional baseline studies:

  • LDH, beta-2 microglobulin, calcium, creatinine
  • Coombs test (autoimmune hemolysis can occur with CLL or plasma cell disorders)

Clinical Context Matters

If Lymphocytosis Predominates:

Suspect CLL if 4, 5, 6:

  • Sustained lymphocytosis ≥5 × 10⁹/L with small, mature-appearing lymphocytes
  • The SPEP may show hypogammaglobulinemia or a small monoclonal protein (common in elderly CLL patients with concurrent MGUS)

Next steps for CLL evaluation:

  • Flow cytometry immunophenotyping: CD5+, CD19+, CD20+ (dim), CD23+, surface Ig (dim)
  • FISH cytogenetics for risk stratification
  • Physical exam focusing on lymphadenopathy (≥10 cm = massive), splenomegaly (≥6 cm below costal margin = massive)

Treatment is NOT indicated unless 4:

  • Progressive marrow failure (worsening anemia/thrombocytopenia)
  • Massive or progressive lymphadenopathy/splenomegaly
  • Lymphocyte doubling time <6 months (requires serial counts over 2-3 months)
  • Constitutional symptoms (≥10% weight loss in 6 months, fever >38°C for >2 weeks, significant fatigue)

If Monoclonal Protein is Present or Suspected:

The abnormal sFLC ratio is the key discriminator 1, 7:

  • Abnormal ratio + monoclonal protein = urgent hematology referral to exclude AL amyloidosis or multiple myeloma
  • Chronic renal insufficiency can cause mildly elevated kappa and lambda (with preserved ratio) - this is NOT a plasma cell dyscrasia

Risk stratification for progression 7:

  • High risk: M-protein ≥15 g/L, IgA or IgM type, abnormal sFLC ratio
  • These patients need bone marrow biopsy at baseline

Bone marrow examination is required if 7, 8:

  • Unexplained anemia, renal insufficiency, hypercalcemia, or bone lesions
  • M-protein >15 g/L
  • IgA or IgM monoclonal protein
  • Abnormal sFLC ratio

Critical Pitfalls to Avoid

  1. Do not rely on SPEP alone - Small monoclonal proteins are missed without immunofixation, and light chain-only disease requires sFLC assay 1, 2

  2. Do not assume leukocytosis alone indicates treatment - In CLL, absolute lymphocyte count is NOT a sole treatment indication; symptoms and organ dysfunction drive treatment decisions 4

  3. Do not delay if AL amyloidosis suspected - This requires urgent hematology referral as it's rapidly progressive 1

  4. Recent IVIG can cause false M-spikes - If patient received IVIG within 30 days, this can create a false positive SPEP 9. Confirm with SIFE and clinical context.

  5. Manual differential is mandatory - Automated counts miss dysplasia, left shifts, and abnormal cell morphology 3

Follow-up Timeline

  • If high-risk features present (abnormal sFLC ratio, M-protein >15 g/L, cytopenias): Hematology referral within 1 week
  • If CLL suspected with rapid progression (lymphocyte doubling time <6 months): Repeat CBC in 2-4 weeks to document trend 4, 10
  • If low-risk MGUS (M-protein <15 g/L, IgG type, normal sFLC ratio): Repeat SPEP in 6 months, then every 2-3 years if stable 7

The worsening leukocytosis one week after SPEP suggests either disease progression or an incomplete initial workup - completing the monoclonal protein evaluation with immunofixation and sFLC assay is non-negotiable before determining next steps.

References

2
Research

Sequence of testing for monoclonal gammopathies.

Archives of pathology & laboratory medicine, 1999

Related Questions

When should Serum Protein Electrophoresis (SPEP) be performed?
What are the next steps for an adult patient with an abnormal Serum Protein Electrophoresis (SPEP) result, possibly indicating multiple myeloma or lymphoma, and presenting with symptoms such as anemia, bone pain, or recurrent infections?
When should serum protein electrophoresis (SPE) be considered in adults over 40 with symptoms such as anemia, bone pain, or recurrent infections?
What are the implications and management of false positives in Serum Protein Electrophoresis (SPEP)?
What type of specimen is required for a Serum Protein Electrophoresis (SPEP)?
What are the possible causes of spider veins in a 27-year-old female?
What is the appropriate diagnostic approach for a high ankle sprain in a young, active athlete who sustained a sudden external‑rotation injury with proximal ankle pain and difficulty weight‑bearing?
What are prostaglandin analogs?
In a man with normal total testosterone but low dihydrotestosterone (DHT), should treatment be initiated?
What is the recommended antibiotic and surgical management for acute mastoiditis?
For esketamine (Spravato), what factors determine whether to start with a 84 mg dose versus a 56 mg dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.